Ann: US Patent Granted for ATL1102 in Duchenne muscular dystrophy, page-8

I love this
”increases the value of Atl1102”
——————-
“It is very gratifying to see this patent granted,” commented Percheron CEO, Dr JamesGarner. “The company has put a persuasive body of evidence to patent agencies in keyterritories, who have reviewed it in detail. The granting of a patent such as thissubstantially increases the value of ATL1102, and will no doubt be enormously helpful inour future discussions with partners and investors.”

People ignore the noise from outside
Believe in PER and the Board
This is >$5 in time
Re read all the past announcements